WASHINGTON (Reuters) - Aqua Bounty Technologies Inc’s genetically engineered salmon are as safe to eat as normal Atlantic salmon, U.S. regulators said in a preliminary analysis released on Friday.
LONDON (Reuters) - People who take a commonly used class of osteoporosis drugs called bisphosphonates for more than five years may be doubling their risk of developing cancer of the gullet or esophagus, a British study found on Friday.
CHICAGO (Reuters) - Teenagers who sleep less than eight hours a night on weeknights eat more fatty foods and snacks than those who get more than eight hours of sleep a night, U.S. researchers said on Wednesday.
LONDON (Reuters) - Tens of millions of people in low and middle income countries would be pushed below the poverty line by buying common but vital medicines which are already unaffordable to hundreds of millions more, a study has found.
LONDON (Reuters) - A new molecular test for tuberculosis made by Cepheid can diagnose TB and detect a drug-resistant form of it far more easily and rapidly than other tests currently available, scientists said on Wednesday.
CHICAGO (Reuters) - The common diabetes drug metformin may hold promise as a way to keep smokers from developing lung cancer, U.S. researchers said on Wednesday.
NEW YORK (Reuters Health) - While staying mentally active in old age has been linked to a delayed onset of dementia, seniors who engage in such brain “exercise” may actually have a faster rate of decline once Alzheimer’s is diagnosed, researchers reported Wednesday.
LONDON (Reuters) - Tens of millions of people in low and middle income countries would be pushed below the poverty line by buying common but vital medicines which are already unaffordable to hundreds of millions more, a study has found.
WASHINGTON (Reuters) - The Obama administration asked a federal judge on Tuesday to lift an injunction halting human embryonic stem cell research, saying it would irreparably harm research and cost more than 1,300 jobs.
CHICAGO (Reuters) - Women with mutations in the well-known BRCA1 or BRCA2 genes who have their breasts and ovaries removed are much more likely to survive than women who do not get preventive surgery, U.S. researchers said on Tuesday.